OUTCOMES OF OXALIPLATIN- BASED ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: A RETROSPECTIVE STUDY AT HANOI MEDICAL UNIVERSITY HOSPITAL. YHCĐ [Internet]. 2026 Oct. 30 [cited 2026 Nov. 8];67(10). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/6925